Company news: Pfizer, Projects in Knowledge

Share this article:
Eleven weeks after going generic, Lipitor is holding its ground with a little over a third of the market, according to a research note by Credit-Suisse analyst Michael Faerm. Lipitor sales accounted for 35.8% of the market for the week ended February 17, a minor dip from 36.2% the week ended February 10. This shift is in step with generic Lipitor, which held 63.8% of the market share for the week ended February 17, compared to 64.2% for the same period. Faerm notes that Lipitor captured 23.9% of total statin prescriptions for the week ended February 17, but saw slight erosion in new prescriptions, falling to 28% for the same period, compared with 28.4% for the week before.

Projects in Knowledge released its free HCV Care and Guidance iPhone/iPad app. The hepatitis C app provides peer-reviewed education about direct-acting antiviral treatments and updated HCV infection information. The Centers for Disease control estimates that more than 4 million Americans have chronic viral hepatitis B or C.

Industry research firm Cegedim says its relationship marketing database, OneKey, now includes more than 8 million validated healthcare professional profiles. The company said in a statement that the database includes professionals in over 69 countries. Profiles are updated annually and is managed to adhere to local privacy regulations, according to the company's Web site.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Genentech shift could prove costly for hospitals

Genentech will use specialty distributors rather than wholesalers, hospitals pharmacy directors have learned.

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies